Pearl River Capital’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-4,175	Closed	-$211K	–	453
2021 Q3	$211K	Buy	+4,175	New	+$211K	0.06%	370
2019 Q2	–	Sell	-294	Closed	-$6K	–	325
2019 Q1	$6K	Buy	+294	New	+$6K	0.01%	320